gabexate has been researched along with carbon tetrachloride in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kobayashi, M; Watanabe, A; Yamauchi, Y | 1 |
| Goto, T; Kataoka, E; Lin, JG; Mikami, K; Miura, K; Ohshima, S; Segawa, D; Shibuya, T; Watanabe, D; Watanabe, S; Yoneyama, K | 1 |
2 other study(ies) available for gabexate and carbon tetrachloride
| Article | Year |
|---|---|
Anti-carcinogenic effects of a serine protease inhibitor (FOY-305) through the suppression of neutral serine protease activity during chemical hepatocarcinogenesis in rats.
Topics: Animals; Antineoplastic Agents; Carbon Tetrachloride; Endopeptidases; Esters; Gabexate; gamma-Glutamyltransferase; Guanidines; Liver; Liver Neoplasms, Experimental; Male; Protease Inhibitors; Rats; Rats, Inbred Strains; Serine Endopeptidases | 1987 |
Gabexate mesilate, a synthetic protease inhibitor, attenuates carbon tetrachloride-induced liver injury in rats.
Topics: Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Disease Progression; Enzyme-Linked Immunosorbent Assay; Gabexate; Interleukin-1; Lethal Dose 50; Liver; Liver Diseases; Male; Rats; Rats, Sprague-Dawley; Serine Proteinase Inhibitors; Transaminases; Tumor Necrosis Factor-alpha | 2005 |